甲亢性骨质疏松症治疗中应用骨化三醇治疗的临床观察  

Observation of Clinical Effect on Calcitriol to Hyperthyroidism Osteoporosis

作　　者：齐晨蕊[1] 

机构地区：[1]吉林省人民医院内分泌一科,长春130021

出　　处：《中国继续医学教育》2015年第7期231-232,共2页China Continuing Medical Education

摘　　要：目的观察甲亢性骨质疏松症治疗中骨化三醇的应用效果。方法选取我院收治的甲亢性骨质疏松症患者88例,将其随机分为观察组与对照组,对照组采用抗甲状腺药物联合阿仑膦酸钠片治疗;在此基础上,观察组加用骨化三醇治疗,比较两组治疗效果。结果治疗后,观察组总有效率高于对照组,疼痛评分低于对照组,有统计学意义(P<0.05)。结论骨化三醇治疗甲亢性骨质疏松症的临床疗效显著。Objective To observe the effect of calcitriol to hyperthyroidism osteoporosis. Methods 88 patients with osteoporosis hyperthyroidism in our hospital were randomly selected into observation group and control group, the patients of control group were treated with anti-thyroid drug combined with alendronate sodium tablets. On the basis of the treatment, the observation group patients were treated with calcitriol. Then, the effects were compared. Results The total effective rate of the observation group was higher than the control group significantly, the pain scores was lower than the control group significantly（P〈0.05）. Conclusion The clinical effect of calcitriol to hyperthyroidism osteoporosis is obvious. It is worthy to be promoted.

关 键 词：甲亢 骨质疏松症 骨化三醇 

分 类 号：R580[医药卫生—内分泌]